Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportMolecular Targeting Probes-Radioactive & Nonradioactive - Preclinical Probes for Oncology

Library Optimization of Fluorine-Containing FC131 Analogues as CXCR4-Targeted Peptide Radiopharmaceuticals

Julia Mason and Leonard Luyt
Journal of Nuclear Medicine June 2024, 65 (supplement 2) 242330;
Julia Mason
1Western University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Leonard Luyt
1Western University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

242330

Introduction: The CXCR4 receptor is highly expressed in numerous tumour types, thus the development of targeted imaging agents could play an imperative role in the diagnosis and treatment of various cancers. In recent years, several ligands have been found to target CXCR4, including the peptide FC131, but these have not yet been developed into clinical 18F-PET imaging agents. The objective is to create a library of fluorine-containing FC131 analogues with optimization through structural modifications of stereochemistry, N-methylation, side-chain length, and linker composition.High affinity library leads will be conjugated with a 18F-labelled prosthetic group using strain-promoted alkyne-azide cycloaddition (SPAAC) and evaluated.

Methods: A fluoro-azadibenzocyclooctyne (19F-ADIBO) was synthesized and conjugated to the peptides through SPAAC.<w:sdt docpart="A6BDF94BFF0E03449AA04E9D48F44B01" id="71640632" sdttag="MENDELEY_CITATION_v3_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">1</w:sdt> FC131 analogues were synthesized using standard Fmoc solid-phase peptide synthesis, purified by preparative HPLC, and characterized by high-resolution mass spectrometry. Binding affinity towards CXCR4 was evaluated through a competitive radioligand displacement binding assay using U87 CD4+CXCR4+ cells.<w:sdt docpart="1DF03B440900304AA47E2740B09D7711" id="-1914853633" sdttag="MENDELEY_CITATION_v3_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">2</w:sdt> The azadibenzocyclooctyne prosthetic group precursor was synthesized to produce 18F-ADIBO as a prosthetic group for radiofluorination of lead peptides.

Results: A library of FC131 peptides conjugated to a 19F-ADIBO imaging moiety was synthesized. Exhibited by previous FC131 investigations, the Arg3 position was chosen to append the imaging moiety as it has been shown to be effectively modified without receptor affinity interference.<w:sdt docpart="D42F1385BD24D041A9F6A9B8AADA85A2" id="688261670" sdttag="MENDELEY_CITATION_v3_eyJjaXRhdGlvbklEIjoiTUVOREVMRVlfQ0lUQVRJT05fZWQ2NWVmZWUtMmVkZi00YTVkLTlkZGItOTBjYmE5ZjkyOWViIiwicHJvcGVydGllcyI6eyJub3RlSW5kZXgiOjB9LCJpc0VkaXRlZCI6ZmFsc2UsIm1hbnVhbE92ZXJyaWRlIjp7ImlzTWFudWFsbHlPdmVycmlkZGVuIjpmYWxzZSwiY2l0ZXByb2NUZXh0IjoiPHN1cD4zPC9zdXA+IiwibWFudWFsT3ZlcnJpZGVUZXh0IjoiIn0sImNpdGF0aW9uSXRlbXMiOlt7ImlkIjoiNDg5OTVmZmItMmU4OS0zNjY4LWFhZjAtZjBlN2JmZGQ5ODhmIiwiaXRlbURhdGEiOnsidHlwZSI6ImFydGljbGUtam91cm5hbCIsImlkIjoiNDg5OTVmZmItMmU4OS0zNjY4LWFhZjAtZjBlN2JmZGQ5ODhmIiwidGl0bGUiOiJQRVQgSW1hZ2luZyBvZiBDWENSNCBSZWNlcHRvcnMgaW4gQ2FuY2VyIGJ5IGEgTmV3IE9wdGltaXplZCBMaWdhbmQiLCJhdXRob3IiOlt7ImZhbWlseSI6IkRlbW1lciIsImdpdmVuIjoiT2xpdmVyIiwicGFyc2UtbmFtZXMiOmZhbHNlLCJkcm9wcGluZy1wYXJ0aWNsZSI6IiIsIm5vbi1kcm9wcGluZy1wYXJ0aWNsZSI6IiJ9LHsiZmFtaWx5IjoiR291cm5pIiwiZ2l2ZW4iOiJFbGVuaSIsInBhcnNlLW5hbWVzIjpmYWxzZSwiZHJvcHBpbmctcGFydGljbGUiOiIiLCJub24tZHJvcHBpbmctcGFydGljbGUiOiIifSx7ImZhbWlseSI6IlNjaHVtYWNoZXIiLCJnaXZlbiI6IlVkbyIsInBhcnNlLW5hbWVzIjpmYWxzZSwiZHJvcHBpbmctcGFydGljbGUiOiIiLCJub24tZHJvcHBpbmctcGFydGljbGUiOiIifSx7ImZhbWlseSI6Iktlc3NsZXIiLCJnaXZlbiI6IkhvcnN0IiwicGFyc2UtbmFtZXMiOmZhbHNlLCJkcm9wcGluZy1wYXJ0aWNsZSI6IiIsIm5vbi1kcm9wcGluZy1wYXJ0aWNsZSI6IiJ9LHsiZmFtaWx5IjoiV2VzdGVyIiwiZ2l2ZW4iOiJIYW5zLUrDvHJnZW4iLCJwYXJzZS1uYW1lcyI6ZmFsc2UsImRyb3BwaW5nLXBhcnRpY2xlIjoiIiwibm9uLWRyb3BwaW5nLXBhcnRpY2xlIjoiIn1dLCJjb250YWluZXItdGl0bGUiOiJDaGVtTWVkQ2hlbS4iLCJjb250YWluZXItdGl0bGUtc2hvcnQiOiJDaGVtTWVkQ2hlbSIsImFjY2Vzc2VkIjp7ImRhdGUtcGFydHMiOltbMjAyMCw4LDNdXX0sIkRPSSI6IjEwLjEwMDIvY21kYy4yMDExMDAzMjAiLCJJU1NOIjoiMTg2MDcxNzkiLCJVUkwiOiJodHRwOi8vZG9pLndpbGV5LmNvbS8xMC4xMDAyL2NtZGMuMjAxMTAwMzIwIiwiaXNzdWVkIjp7ImRhdGUtcGFydHMiOltbMjAxMSwxMCw0XV19LCJwYWdlIjoiMTc4OS0xNzkxIiwidm9sdW1lIjoiNiJ9LCJpc1RlbXBvcmFyeSI6ZmFsc2V9XX0=">3</w:sdt> Initial library analogues demonstrated that direct attachment of the imaging moiety through a triazole ring resulted in loss of affinity. This attachment disrupted essential ligand-receptor binding interactions, irrespective of amino acid stereochemistry or length, as well as backbone N-methylation. Efforts to extend the space to F-ADIBO through a 4-(azidomethyl)benzoic acid linker improved binding affinity. The addition of a linker region that incorporated hydrogen bonding/positively charged amino acids resulted in lead peptides with high receptor affinity. Library leads are subsequently being labelled with the 18F-analogue of the cyclooctyne prosthetic group to be translated into PET cancer imaging probes.

Conclusions: A library of fluorine-containing FC131 peptides was synthesized and screened against the CXCR4 receptor, a cancer biomarker of interest. Optimization of the attachment site of F-ADIBO resulted in peptides with significantly improved binding affinity. Library leads are being directly translated into PET cancer imaging probes through the substitution of the 19F-ADIBO prosthetic group with its 18F analogue to be evaluated in vitro and in vivo.

Acknowledgements

Funding: National Sciences and Engineering Research Council of Canada (NSERC). Molecular Imaging Collaborative Program, University of Western Ontario. The following reagents were obtained through the NIH HIV Reagent Program, Division of AIDS, NIAID, NIH: U87 CD4+CXCR4+ cells, ARP-4036, contributed by Drs. HongKui Deng and Dan R. Littman.

Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 65, Issue supplement 2
June 1, 2024
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Library Optimization of Fluorine-Containing FC131 Analogues as CXCR4-Targeted Peptide Radiopharmaceuticals
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Library Optimization of Fluorine-Containing FC131 Analogues as CXCR4-Targeted Peptide Radiopharmaceuticals
Julia Mason, Leonard Luyt
Journal of Nuclear Medicine Jun 2024, 65 (supplement 2) 242330;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Library Optimization of Fluorine-Containing FC131 Analogues as CXCR4-Targeted Peptide Radiopharmaceuticals
Julia Mason, Leonard Luyt
Journal of Nuclear Medicine Jun 2024, 65 (supplement 2) 242330;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Synthesis of a modified SiFA-PSMA inhibitor and its in vitro and in vivo analysis
  • Automatic Production and Preclinical Evaluation of 11C-labeled Thiolactic Acid for Cancer Imaging
  • In vivo PET imaging of 5T4 positive tumor cells using 89Zr-DFO-MY9
Show more Molecular Targeting Probes-Radioactive & Nonradioactive - Preclinical Probes for Oncology

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire